Selectis Health, Inc.
GBCS
$3.10
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | -100.00% | -74.73% | -49.36% |
| Total Other Revenue | 5.80% | 11.50% | 12.69% | 11.91% | 8.36% |
| Total Revenue | 4.94% | 10.10% | 10.76% | 10.41% | 7.36% |
| Cost of Revenue | 4.61% | 7.91% | 4.35% | 1.88% | -3.24% |
| Gross Profit | 6.01% | 18.35% | 38.71% | 51.51% | 68.91% |
| SG&A Expenses | -5.05% | -22.36% | -15.31% | -14.95% | -18.97% |
| Depreciation & Amortization | -6.08% | -11.29% | -9.82% | -8.59% | -5.78% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.86% | -1.11% | -1.60% | -3.19% | -7.70% |
| Operating Income | 42.67% | 77.49% | 68.82% | 68.06% | 69.54% |
| Income Before Tax | 58.13% | 85.62% | 48.70% | 77.35% | 38.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 58.10% | 85.62% | 48.70% | 77.35% | 38.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.10% | 85.62% | 48.70% | 77.35% | 38.96% |
| EBIT | 42.67% | 77.49% | 68.82% | 68.06% | 69.54% |
| EBITDA | 92.22% | 104.69% | 87.07% | 84.34% | 84.11% |
| EPS Basic | 56.95% | 85.19% | 48.66% | 77.18% | 39.10% |
| Normalized Basic EPS | 58.40% | 75.64% | 59.89% | 56.15% | 58.07% |
| EPS Diluted | 57.09% | 84.37% | 48.22% | 76.80% | 38.55% |
| Normalized Diluted EPS | 58.40% | 75.64% | 59.89% | 56.15% | 58.07% |
| Average Basic Shares Outstanding | 0.00% | 0.10% | 0.20% | 0.31% | 0.41% |
| Average Diluted Shares Outstanding | 0.00% | 0.10% | 0.20% | 0.31% | 0.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |